Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001140361-16-046270

Director acquired 26,661 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
KIRK RANDAL J Director 2015-12-31 Grant or award +26,661 122,309 D: show line 1 in the form
Loading xslF345X03/doc1.xml…